RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY The ESMO , conference is about 10 days from now.
Not Onc , but two outside trial managers will be presenting two posters/ abstracts.
they will be detailing results, I believe one on MBc & the other on pancancer.
based on previous conferences comments, the expectation is to have some very spectacular results.
The abstracts have been in possession of ESMO for a while.
All under embargo.
Meaning the details of will not be made public before a certain time & date.
under reporting rules,any milestone " news" must be reported through media channels.
for example P; newswire, SEDAR & various NAS reporting methods.
point being everyone gets the information at the same time.
that process ensures no " insider" opportunities.
Assuming there is some excelent results, Onc will as close to presentation date as ESMO will allow, be posting a N.R.
so, about ten more days .
looking at the trading?
very low volume. Price moving up & down, certainly not in an6 significant indication.
meanning. There is neither s massive sell-off , or a serious. Buying interest.
there is a larger % of shorting. That is never good for the SP.
the ESMO is the only known upcoming event.
It is not listed on Onc web site, because whioe the product is being featured. Onc is not the presenter.
As a minium watch for a N.R. Indicating the acstracts are being presented.
That is about it for the process.
Results?
Good things are expected.
So, like me many are in wait & see mode.